Ministry of Health with MSF doctor discussing individual treatment and case management strategies
In Uzbekistan, Doctors Without Borders (MSF) works with the Ministry of Health to improve diagnostics and treatment for people with tuberculosis (TB), including drug-resistant forms of the disease, and provide HIV care.

In 2020, in collaboration with the health ministry, we updated the national protocol to support the use of an all-oral short-course TB regimen with bedaquiline as a core component. Bedaquiline is a highly effective drug that has been proven to improve outcomes for patients. The protocol now also includes a section on palliative care for TB patients who have limited therapeutic options.

In our project in Karakalpakstan, we continued to roll out the latest evidence-based TB treatment guidelines across all 17 districts.

In September, we launched a new health promotion unit in Nukus, which will conduct awareness sessions in the community as well as health education and support groups for patients in TB facilities. Meanwhile, we are continuing our multi-site clinical trial, TB PRACTECAL, at two sites in Nukus and Tashkent to develop radically improved treatment for people with multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB).

During the global COVID-19 pandemic, we reinforced infection prevention and control measures in healthcare settings, and ensured continuity of care for our HIV and TB patients.

Innovative practices such as Video Observed Treatment (VOT) and Family-Directly Observed Treatment (F-DOT), in which health workers or family members watch the patient take their drugs, played an important role in supporting patients to adhere to their treatment during the lockdown.

We continue to strengthen outpatient models of care that are tailored to patients’ needs and requirements, and expect to roll out VOT and F-DOT further in 2021.

In 2020, MSF started cooperating with the World Health Organization and the Joint United Nations Programme on HIV/AIDS (UNAIDS) to implement the ‘one-stop shop’ model developed in Tashkent, in another region, Syrdarya. The ‘one-stop shop’ is a person-centred approach that allows people living with HIV to receive multidisciplinary care in the same location.

This is the first time that such an approach has been proposed and implemented in Central Asia.

No. staff in 2020: 310 (FTE) » Expenditure in 2020: €7 million MSF first worked in the country: 1997

 
Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB.
Tuberculosis

Trial of MDR-TB treatment ends enrolment early after after positive initial data

Press Release 24 Mar 2021
 
Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB.
Tuberculosis

Trial of MDR-TB treatment ends enrolment early after after positive initial data

Press Release 24 Mar 2021
 
Drug-resistant TB

Uzbekistan: “MSF is giving me a chance to do my favourite job and to gain invaluable experience, which allows me to help even more to people in need.”

Latest News 6 Aug 2015